Infective Endocarditis PPT | Infective Endocarditis Emedicine | Infective Endocarditis Powerpoint | Infective Endocarditis Symptoms | Symptoms Of Endocarditis | ndocarditis Diagnosis | Endocarditis Treatment | Guidelines Infective Endocarditis: SlideWorld Medical PPT Search Engine

Infective endocarditis

Rating :

Rate It:

Send This

Download

Comment

Favourite

more

Post To:

Facebook

Twitter

Digg

Delicious

more share options

There is no comments now for this Slide.

Post a comment

Post Comment on Twitter Post Comment on SlideWorld

Comments:

Subscribe to follow-up comments

Notes

Show Notes

Slide 1 :

Epidemiology, Clinical Characteristics and Evolution of Infective Endocarditis in Under-developed Countries: Results of the Argentinian Registries (EIRA) Dr J Horacio Casabé MD, PhD , FACC, MTSAC Fundación Favaloro, Buenos Aires, Argentina World Congress of Cardiology May 18-21 2008 Buenos Aires, Argentina Nothing to disclose

Slide 2 :

The first National survey of IE in Argentina (EIRA-1) was conducted between 1992 and 1993 EIRA Studies Background It was the first multicenter survey done in an underdeveloped country and was published in the Revista Argentina de Cardiologia JH Casabé, CD Pellegrini, AR Hershson, MS Ramos, L Vidal, EA Sampó JL Barisani, L Clara, EA Argüello y SD Varini.Endocarditis Infecciosa en la Republica Argentina. Resultados generales. Rev Argent Cardiol 1996; (Suplemento V):9-19.

Slide 3 :

EIRA 1

Slide 4 :

Multicenter study (33) with 294 episodes in 285 patients according to Duke Criteria included in 18 months 55% had underlying heart disease 63.3% predisposing event ;40 cases (13%)of drug abuse 23,5 % of Hospital Mortality EIRA 1

Slide 5 :

EIRA 1 Symptoms EIRA 1 Symptoms

Slide 6 :

EIRA 1 Signs EIRA 1 Signs

Slide 7 :

EIRA 1 IV Drug abuse patients Rev Argent Cardiol 1996;64: 27-32

Slide 8 :

EIRA 1 IV Drug abuse patients Rev Argent Cardiol 1996;64: 27-32

Slide 9 :

EIRA 1 IV Drug abuse patients Rev Argent Cardiol 1996;64: 27-32

Slide 10 :

Surgical Treatment EIRA 1

Slide 11 :

After 10 years, in 2002-2003 with the objective of determine the epidemiologic, clinical, microbiologic characteristics, and inhospital outcome of IE in Argentina and compare the results with the 1992 IE national survey ,the Argentinian Society of Cardiology (SAC) decided to do a new multicenter Survey: the EIRA 2 study EIRA Studies Rational

Slide 12 :

Am Heart J 2006;151:545-52

Slide 13 :

EIRA 2. Representativity Euro Heart Survey159 cases in 92 centres from 25 countries in 1 year (Heart 2005) French Registry : 26% territory of France, 290 patients (JAMA 2002) International Collaboration on Endocarditis Group(ICE) 1779 EI definite patients during 4 years in 39 centres from16 countries.Average: 111 cases/country/4 years or 28 cases/country/year (JAMA 2005) Endocarditis Infecciosa en la República Argentina(EIRA 2) . > 75% national territory. Average : 260 cases/year (Am Heart J 2006)

Slide 14 :

EIRA-1 EIRA-2 Nº episodes 294 470 N° Definite IE 75,5% 83,0% Age in years (average) 51,3 58,5* Male sex 69,5% 70,0% Underlying heart disease 55% 66,2%* Pathologic confirmation(%) 20,7% 29,2% Diabetes (%) ND 14,6% Previous IE(%) 10,2% 11,3% Previous heart surgery(%) ND 20,8% COPD (%) ND 4,4% Chronic renal failure ND 14,2% EIRA Studies Basal Characteristics * p < 0,01

Slide 15 :

% EIRA Studies Underlying heart disease

Slide 16 :

Microorganisms Negative blood cultures: EIRA 1: 20,4 ; EIRA 2: 17,7% EIRA Studies %

Slide 17 :

Valve involvement % * p < 0,01 * EIRA Studies

Slide 18 :

Time to diagnosis 33,07 ± 34,3 days 21,5 ± 35,3 days p < 0,001 EIRA Studies

Slide 19 :

Evolution: Complications % * p < 0,01 * EIRA Studies

Slide 20 :

Evolution: Surgery and Mortality % p = NS EIRA Studies

Slide 21 :

EIRA Studies S aureus Infective endocarditis

Slide 22 :

% SAIE 108 episodes (30%) vs. NSAIE 282 episodes * p < 0,01 * * * Age SAIE 57,0±17 vs 59,0±17; p = 0,05 EIRA. S aureus Underlying diseases

Slide 23 :

EIRA. S aureus Predisposing factors and concomitant diseases % * p < 0,01 * * * *

Slide 24 :

33,3% TTE / 66,6% TTE + TEE EIRA. S aureus Echocardiogram % Vegetation size(mm) SAIE 17,5 ± 10,1 vs NSAIE 12,7 ± 10,7; p=0,03

Slide 25 :

EIRA. S aureus Localization % * p < 0,01 * *

Slide 26 :

EIRA. S aureus IE Evolution: Complications % * p < 0,01 ** p = 0,14 * * * **

Slide 27 :

EIRA. S aureus IE Surgery Indications % * p = 0,001 ** p = NS * ** **

Slide 28 :

EIRA. S aureus Surgery and Mortality % OR 0,6 (IC 95% 0,36-1,2) p=NS OR 2,0 (IC 95% 1,2-3,3) p=0,009

Slide 29 :

Increase of S aureus as etiologic agent

Slide 30 :

Clin Infect Dis 2005;41:507-514 Increase of S aureus as etiologic agent

Slide 31 :

Increase of S aureus as etiologic agent

Slide 32 :

In the last 10 years clinical profile of IE has changed in Argentina Currently patients are older (7 years) and have a higher frequency of underlying heart disease, degenerative valve disease,and prosthetic valve. Intravascular catheters and predisposing factors are more prevalent than previously There is an increase of congenital heart disease and a decrease of rheumatic heart disease as underlying heart disease in the group of patients aged < 40 years . EIRA Studies : Conclusions (1)

Slide 33 :

The incidence of S aureus IE has increased.; it was an inversion in the prevalence(S viridans : S aureus) Patients with S aureus IE have a high risk profile and worse hospital evolution (more embolism, CVA, septic shock and mortality) Despite advances in surgical treatment and earlier time to diagnosis,the incidence of complications and mortality has not been reduced EIRA Studies : Conclusions (2)

Slide 34 :

EIRA Studies : Conclusions (3) One likely explanation for the absence of a positive correlation with better outcome might be the higher risk profile of the EIRA-2 patient (older population, higher prevalence of valve prostheses,increased proportion of staphylococci IE). Hypothesis

Slide 35 :

Participant Provinces: 16 Medical Centers: 146 EIRA Studies Acknowledgments Coordinating Center Mario Ciruzzi, Ernesto Ferreirós, Sandra Swieszkowski, Juan Carlos Modenesi, Francisco Nacinovich, José H. Casabé y Sergio Varini. Regional Coordinators Hernán Cohen Arazi, Adriana Angel, Cecilia Zevallos, Lucía Kazelian, Claudia Cortés, Román Cragnolino, Mariano Falconi, Alejandra Francesia, Mariano Giorgi, Claudio Higa, Pablo Schygiel, Alejandra von Wulffen.

Slide 36 :

EIRA Studies Thank you for your attention Lago Gutierrez, Bariloche, Argentina

	jhcasabe@ffavaloro.org 1 Years ago. Category: Internal Medicine

Tags:	Internal Medicine

Embed:
680 Views, 0 favourite
PowerPoint Presentation on Infective endocarditis or PowerPoint Presentation on Epidemiology of Inf more PowerPoint Presentation on Infective endocarditis or PowerPoint Presentation on Epidemiology of Infectrive endocarditis less

SWINE Flu

Why do women live longer then men? Humor

History of Medicine

Yoga and Medicine

How to be a Successful Interventional Fellow size 50 MB

Cardiac Pathology

Hypertension: New Concepts, Guidelines, and Clinical Management

Diabetes Pathology

Medical Powerpoint Templates
(20% Dicsount For Student/Faculty)